Wireless neural recording devices for brain monitoring
Optical neural motes to enable high density recording through intact dura in a nonhuman primate
This study is working on a new wireless device called ReMote that can safely record brain activity using light, making it easier for researchers to monitor how the brain works over time without causing much harm, starting with tests on animals like rats and eventually moving to primates.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10516965 on NIH RePORTER |
What this research studies
This research focuses on developing a wireless neural recording probe called ReMote, which uses near-infrared light for power and communication. The device features tiny carbon fiber electrodes that can be implanted with minimal bleeding and scarring, allowing for high-density recordings from the brain. The project involves designing the electronic components, packaging the electrodes, and validating the device through animal testing, starting with rats and progressing to nonhuman primates. The aim is to create a system that can monitor brain activity over extended periods without invasive procedures.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals with neurological conditions that require monitoring of brain activity.
Not a fit: Patients without neurological disorders or those who do not require invasive brain monitoring may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advanced methods for monitoring brain activity in real-time, improving our understanding of brain disorders.
How similar studies have performed: While similar technologies have been explored, this specific approach using wireless neural recording devices is innovative and has not been widely tested in this manner.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Blaauw, David — University of Michigan at Ann Arbor
- Study coordinator: Blaauw, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.